Reference:
- WHO Timeline-COVID 19. (2020, April27). Retrieved from
https://www.who.int/news-room/detail/27-04-2020-who-timeline—covid-19
- American journal of emergency medicine PE case report
- Guan W.J., Ni Z. Y., Liang W.H., Ou C Q. Clinical characteristics of
coronavirus disease 2019 in China. N. Engl. J. Med. 28 Feb 2020
[Google Scholar]
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease
2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases
From the Chinese
Center for Disease Control and Prevention. Jama 2020.
- Chen G., Wu D., Cao Y., Huang D. Clinical and immunologic features in
severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020
Mar 27 (pii:137244) [Google Scholar]
- Han H., Yang L., Liu R., Liu F., Wu K.L. Prominent changes in the
blood coagulation of the patients with SARS-CoV-2 infection. Clin.
Chem Lab Med (CCLM) Mar 2020 [Google Scholar]
- Tolouian, R., Vahed, S. Z., Ghiyasvand, S., Tolouian, A., & Ardalan,
M. (2020). COVID-19 interactions with angiotensin-converting enzyme 2
(ACE2) and the kinin system; looking at a potential treatment.Journal of Renal Injury Prevention , 9 (2). doi:
10.34172/jrip.2020.19
- Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., …
Ning, Q. (2020). Clinical characteristics of 113 deceased patients
with coronavirus disease 2019: retrospective study. Bmj , m1091.
doi: 10.1136/bmj.m1091
- Poissy, J., Goutay, J., Caplan, M., Parmentier, E., Duburcq, T.,
Lassalle, F., … Susen, S. (2020). Pulmonary Embolism in
COVID-19 Patients: Awareness of an Increased Prevalence.Circulation . doi: 10.1161/circulationaha.120.047430
- Tang Nig. Anticoagulant treatment is associated with decreased
mortality in severe coronavirus disease 2019 patients with
coagulopathy. J. Thromb. Haemost. 27 Mar. 2020 [Google Scholar]